Print-ready dossier — use your browser's print dialog to save as PDF.
AESKULISA® ß2-Glyco-GM
Model 3206 · Aesku.Diagnostics GmbH & Co. KG · DI 04250289500869
MSV — System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) · Class II · 21 CFR 866.5660
UDILibrary device dossier · generated 2026-09-12 · sources: FDA GUDID, openFDA (recalls, MAUDE, 510(k)/PMA), FDA Data Dashboard (inspections, compliance actions), 510(k) summary documents.
Recall history (0)
No recalls linked in the loaded window.
Adverse-event reports — MAUDE (0)
Caveat (required reading): MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line is a reporting baseline (average device in the same product code), not a risk measure.
| Month | This device (reports) | Product-code average (reports per device) |
|---|---|---|
| 2023-03 | 0 | 1 |
Regulatory clearances
- None linked in the loaded window.
Manufacturer compliance record — Aesku.Diagnostics GmbH & Co. KG
- VAI 2017-03-02 Aesku Group GmbH & Co. KG · 2 citations